NHL35700
- Generic Name
- NHL35700
Study With Lu AF35700 in Healthy Men and Women in Fasting and Fed State
- First Posted Date
- 2018-09-13
- Last Posted Date
- 2019-11-01
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 10
- Registration Number
- NCT03670082
- Locations
- 🇬🇧
Covance, Leeds, United Kingdom
Pharmacokinetics of Lu AF35700 in Subjects With Renal Impairment
- First Posted Date
- 2017-08-07
- Last Posted Date
- 2019-09-30
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 23
- Registration Number
- NCT03241147
- Locations
- 🇩🇪
APEX, Munich, Germany
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
- Conditions
- Treatment-resistant Schizophrenia
- Interventions
- First Posted Date
- 2017-07-27
- Last Posted Date
- 2020-01-21
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 119
- Registration Number
- NCT03230864
- Locations
- 🇧🇬
DCC St. Vrach and St.St. Kuzma and Damian, Sofia, Bulgaria
🇧🇬MHC - Sofia, Sofia, Bulgaria
🇧🇬UMHAT, Pleven, Bulgaria
Effects of Repeated Doses of Lu AF35700 on Drug Metabolizing Enzymes
- Conditions
- Drug Reactions
- Interventions
- First Posted Date
- 2017-06-22
- Last Posted Date
- 2018-01-08
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 24
- Registration Number
- NCT03195946
- Locations
- 🇬🇧
Covance Clinical Research Unit Ltd, Leeds, United Kingdom
Study Investigating the Pharmacokinetic Properties of the Drug Lu AF35700 in Subjects With Liver Impairment and in Healthy Subjects
- First Posted Date
- 2017-06-16
- Last Posted Date
- 2018-05-04
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 24
- Registration Number
- NCT03189615
- Locations
- 🇩🇪
APEX, Munich, Germany
Study Evaluating the Effect of Multiple Doses of Itraconazole on the Drug Lu AF35700 in Healthy Young Men and Women
- Conditions
- Cytochrome P450 Interaction
- Interventions
- First Posted Date
- 2017-04-06
- Last Posted Date
- 2019-10-02
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 22
- Registration Number
- NCT03103646
- Locations
- 🇬🇧
Covance Clinical Research Unit Ltd, Leeds, United Kingdom
🇺🇸Covance - Dallas, Dallas, Texas, United States
Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With Schizophrenia
- First Posted Date
- 2016-09-08
- Last Posted Date
- 2020-10-26
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 528
- Registration Number
- NCT02892422
- Locations
- 🇺🇸
US1244, Fresh Meadows, New York, United States
🇺🇸US1404, Shreveport, Louisiana, United States
🇺🇸US1190, Staten Island, New York, United States
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
- Conditions
- Schizophrenia
- Interventions
- First Posted Date
- 2016-03-23
- Last Posted Date
- 2019-11-25
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 1098
- Registration Number
- NCT02717195
- Locations
- 🇧🇬
BG1029, Veliko TÅrnovo, Bulgaria
🇲🇽MX1011, Guadalajara, Mexico
🇲🇽MX1022, Guadalajara, Mexico
Positron Emission Tomography (PET) Study Investigating Dopamine and Serotonin Receptor Occupancy After Multiple Oral Dosing of Lu AF35700
- First Posted Date
- 2015-01-07
- Last Posted Date
- 2020-05-12
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 22
- Registration Number
- NCT02333487
- Locations
- 🇺🇸
US802, Rockville, Maryland, United States
Safety and Tolerability Study of Lu AF35700 After Repeated Dosing in Patients With Schizophrenia
- First Posted Date
- 2014-07-28
- Last Posted Date
- 2015-03-06
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 96
- Registration Number
- NCT02202226
- Locations
- 🇺🇸
PAREXEL Phase I Unit, Glendale, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.